Vivos Therapeutics, Inc. VVOS
Set alert
0.11 USD -0.01 -4.83%
At close
0.11 0.00 -0.74%
Pre-market · Nov 3, 8:00 AM ET
0.1081 Day range 0.1192
0.108 52-week range 2.72
- YTD
- -94.67%
- 1 year
- -95.62%
- Open
- 0.114
- Prev close
- 0.1138
- Mkt cap
- 3.64M
- Vol
- 617.17K
- Avg vol
- 15.04M
- EPS
- -1.88
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1081
- High
- 0.1192
- Forward P/E
- -9.31
- Beta
- 7.68
- Short ratio
- 0.66
- Inst. own
- 13.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 3.32
- 200-d avg
- 2.88
- 1y target
- 6.30
MAX chart
Events in this range
- Oct 27, 2023Split: 1 for 25
- Mar 28, 2024Earnings: -3.05; estimate 0; surprise —%
- May 14, 2024Earnings: -1.63; estimate 0; surprise —%
- May 14, 2024Earnings: —; estimate 0; surprise —%
- Aug 14, 2024Earnings: -0.6; estimate 0; surprise —%
- Aug 14, 2024Earnings: —; estimate 0; surprise —%
- Aug 20, 2024Rating: Ascendiant Capital · Buy → Buy
- Nov 14, 2024Earnings: -0.4; estimate -0.7; surprise 42.86%
- Nov 19, 2024Rating: Alliance Global Partners · Buy → Buy
- Nov 20, 2024Rating: Ascendiant Capital · Buy → Buy
Signals (76)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 20, 2026 | 6 months ago |
| RSI: Oversold | Apr 20, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| RSI: Overbought | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | May 12, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
Newest 20 of 76.
Analyst view
Consensus: none
Price target (mean) 6.30 +5717.2% upside
Now 0.1083
- Target (low)
- 6.00
- Target (mean)
- 6.30
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43 | -0.43 – -0.43 | -2.76 | +84.4% | 3.89M | +19.6% | 1 |
| Next quarter | -0.41 | -0.41 – -0.41 | -1.63 | +74.9% | 4.10M | +19.9% | 1 |
| Current year | -1.79 | -1.79 – -1.79 | -14.24 | +87.4% | 15.20M | +10.2% | 1 |
| Next year | -1.43 | -1.43 – -1.43 | -1.79 | +20.1% | 19.16M | +26.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Ascendiant Capital | Reiterated | Buy | Buy |
| Nov 19, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Aug 20, 2024 | Ascendiant Capital | Maintained | Buy | Buy |